Dapagliflozin for the treatment of type 1 diabetes mellitus
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2017.1339788
Abstract: ABSTRACT Introduction: In 2017, the management of type 1 diabetes mellitus (T1DM) remains intriguing for the clinician, who has to balance between adequate glycemic control and untoward events related to insulin up-titration. Thus, agents that… read more here.
Keywords: treatment type; dapagliflozin treatment; type diabetes; diabetes mellitus ... See more keywords
Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice
Sign Up to like & getrecommendations! Published in 2022 at "Oxidative Medicine and Cellular Longevity"
DOI: 10.1155/2022/8502059
Abstract: Background Dapagliflozin, a sodium glucose transporter protein-2 (SGLT-2) inhibitor, reduces the risk for cardiovascular diseases. However, the influence of dapagliflozin on nondissecting abdominal aortic aneurysms (AAAs) remains unclear. Methods AAAs were created in male C57BL/6… read more here.
Keywords: abdominal aortic; dapagliflozin treatment; mice; treatment ... See more keywords